Smoking Cessation News and Research

RSS

Aradigm to present Phase 1 studies of inhaled liposomal ciprofloxacin at 2010 ERS Congress

Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.

17 Sep 2010

Smoking cessation offers favorable economic benefits to California

15 Sep 2010

Helping smokers quit also benefits states economically

A new study released today by the American Lung Association, and conducted by researchers at Penn State University, finds that helping smokers quit not only saves lives but also offers favorable economic benefits to states. The study, titled Smoking Cessation: the Economic Benefits, provides a nationwide cost-benefit analysis that compares the costs to society of smoking with the economic benefits of states providing cessation (quit-smoking) coverage.

15 Sep 2010

Exercise training, diet counseling for patients with heart disease risk improves quality of life

A lifestyle intervention incorporating exercise training and diet counseling in primary health care settings appears to improve quality of life among adults at moderate to high risk for heart disease and appears cost-effective compared to standard care, according to a report in the September 13 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

14 Sep 2010

APhA to highlight increasing role of pharmacists in improving health, well-being

In honor of Cholesterol Education Month, The American Pharmacists Association would like to highlight the increasing role of the pharmacist in communities nationwide. In many areas, pharmacists are able to offer cholesterol and blood pressure screenings, as well as other detection and prevention services to help a patient manage their healthcare and get the most out the medications they may be taking.

9 Sep 2010

Reports on smoking rates among Americans reveal dramatic progress in fight against tobacco

Two new reports released today by the Centers for Disease Control and Prevention show that while the United States has made dramatic progress in the fight against tobacco, too many Americans still smoke and too many non-smokers including more than half of all young children are still exposed to secondhand smoke.

8 Sep 2010

Penn receives $12M NIH grant to study pharmacogenetics of nicotine addiction treatment

A variety of smoking cessation treatments are currently available for the more than 18 million adult Americans try to quit smoking each year, but success rates vary widely. Despite the importance of quitting smoking, more personalized approaches to smoking cessation treatment are needed to help smokers pick the right method that will work best for them. A major new personalized medicine clinical trial, led by addiction researchers at the University of Pennsylvania, will study how a smokers' genetic make-up influences their quitting success.

8 Sep 2010

New study may change the way clinicians make treatment decisions for patients who smoke

A study led by researchers in the Oregon Health & Science University Smoking Cessation Center may change the way clinicians make treatment decisions for their patients who smoke.

3 Sep 2010

Diabetes drug metformin exhibits potential against tobacco-induced lung tumors

Metformin, a drug commonly used to treat type 2 diabetes, shows potential in the prevention of tobacco-induced lung tumors, according to early research conducted at the National Cancer Institute (NCI).

3 Sep 2010

Nabi Biopharmaceuticals, Diosynth sign long-term commercial manufacturing agreement

Nabi Biopharmaceuticals announced today that it has entered into a long-term commercial manufacturing agreement with Diosynth RTP, Inc. for the manufacture of Drug Substance integral to the production of NicVAX, Nabi's innovative and proprietary investigational vaccine for the treatment of nicotine addiction and prevention of smoking relapse.

2 Sep 2010

Medicare smoking prevention program could lower costs

A Medicare program that has agreed to pay for counseling for seniors who smoke but are not yet sick could help the program, and America's health system, lower costs.

2 Sep 2010

Anti-smoking measures beefed up

Tasmanians are looking at one of the tightest tobacco control measures ever adopted. The Tasmanian Government is proposing a no-smoking zone at almost all public places including shopping malls and sporting venues and introducing smoke-free buffer zone around children's playgrounds.

31 Aug 2010

Canada should publicly fund smoking cessation pharmacotherapies: CMAJ

Canada should follow the lead of Quebec, Australia and the United Kingdom by publicly funding smoking cessation pharmacotherapies, states an editorial in CMAJ http://www.cmaj.ca/embargo/cmaj101140.pdf.

30 Aug 2010

Alexza Pharmaceuticals licenses Staccato nicotine technology to Cypress Bioscience

Alexza Pharmaceuticals, Inc. announced today that it has licensed its Staccato nicotine technology to Cypress Bioscience, Inc. The Staccato nicotine technology is a novel electronic multidose delivery system designed to help people stop smoking. The Staccato nicotine technology is intended to improve on a well-validated smoking cessation approach by delivering nicotine via inhalation, mimicking the nicotine effects of smoking without the harmful side effects associated with cigarettes.

26 Aug 2010

New test helps to measure smoker's mainstream smoke deliveries of select chemicals per cigarette

A test for one of the thousands of chemicals in cigarette smoke has the potential for more accurately estimating smokers' mouth level exposure and may have applications for developing custom-tailored quitting approaches for the more than 43 million people in the United States who still smoke, and hundreds of millions elsewhere, scientists said here today.

26 Aug 2010

Nabi receives US patent for treatment and prevention of nicotine addiction with NicVAX conjugate vaccines

Nabi Biopharmaceuticals announced the receipt of a patent for treating and preventing nicotine addiction with NicVAX® and related nicotine conjugate vaccines. The United States Patent and Trademark office issued U.S. Patent No. 7,776,620 entitled "Hapten-carrier conjugates for treating and preventing nicotine addiction" for the exclusive use of methods for treating and preventing nicotine addiction with NicVAX and related nicotine vaccines. This patent runs through December 2018.

26 Aug 2010

Statin therapy reduces cardiovascular disease risk in patients with high sensitivity C-reactive protein

People at intermediate risk of cardiovascular disease who have high levels of high sensitivity C-reactive protein (hsCRP), a blood marker for inflammation, could benefit from cholesterol-lowering therapy even if their cholesterol is already at desirable levels.

25 Aug 2010

Researchers find medication for diabetes, smoking cessation

The script for two research teams inducted today into the American Chemical Society (ACS) scientific "hall of fame" the ACS Heroes of Chemistry is a tale of two pills. One team invented a medication that helps people with diabetes control their blood sugar levels. The second team invented a medicine that helps people stop smoking, an addiction that experts regard as today's single greatest preventable cause of death worldwide.

23 Aug 2010

Perry Ellis International launches corporate "Healthy Heart" initiative

Perry Ellis International today unveiled the first in a full roster of community involvement efforts scheduled for this fall.

21 Aug 2010

Study suggests elective surgical repair is safe intervention for abdominal aortic aneurysm

Research from the Society for Vascular Surgery in collaboration with the Mount Sinai School of Medicine Department of Health Evidence and Policy in New York City evaluated the data of 3.1 million patients who were at risk for an abdominal aortic aneurysm (AAA).

20 Aug 2010

Smoking Cessation News and Research

Aradigm to present Phase 1 studies of inhaled liposomal ciprofloxacin at 2010 ERS Congress

Smoking cessation offers favorable economic benefits to California

Helping smokers quit also benefits states economically

Exercise training, diet counseling for patients with heart disease risk improves quality of life

APhA to highlight increasing role of pharmacists in improving health, well-being

Reports on smoking rates among Americans reveal dramatic progress in fight against tobacco

Penn receives $12M NIH grant to study pharmacogenetics of nicotine addiction treatment

New study may change the way clinicians make treatment decisions for patients who smoke

Diabetes drug metformin exhibits potential against tobacco-induced lung tumors

Nabi Biopharmaceuticals, Diosynth sign long-term commercial manufacturing agreement

Medicare smoking prevention program could lower costs

Anti-smoking measures beefed up

Canada should publicly fund smoking cessation pharmacotherapies: CMAJ

Alexza Pharmaceuticals licenses Staccato nicotine technology to Cypress Bioscience

New test helps to measure smoker's mainstream smoke deliveries of select chemicals per cigarette

Nabi receives US patent for treatment and prevention of nicotine addiction with NicVAX conjugate vaccines

Statin therapy reduces cardiovascular disease risk in patients with high sensitivity C-reactive protein

Researchers find medication for diabetes, smoking cessation

Perry Ellis International launches corporate "Healthy Heart" initiative

Study suggests elective surgical repair is safe intervention for abdominal aortic aneurysm

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News